MYOS RENS Technology Inc (MYOS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MYOS RENS Technology Inc (MYOS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8062
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MYOS RENS Technology Inc (MYOS RENS), formerly MYOS Corp is a bionutrition and biotherapeutics company that discovers, develops and commercializes products that improve muscle health and function. The company offers fortetropin, a unique bioactive composition derived from fertilized chicken egg yolk that is processed using a patented technology which preserves its biological integrity and bioactivity for increase of muscle size and lean body mass in conjunction with resistance training. MYOS RENS’s biotherapeutics research and development activities are concentrated on medical health, nutrition, consumer health and animal health. It also undertakes human clinical trials and pre-clinical studies for the treatment of various diseases such as sarcopenia, cachexia and degenerative muscle disease. The company partners with other institutions for its research and development activities. MYOS RENS is headquartered in Cedar Knolls, New Jersey, the US.

MYOS RENS Technology Inc (MYOS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Atlas Therapeutics Raises US$0.73 Million In Venture Financing 10
Partnerships 11
MYOS RENS Technology Enters into Research Agreement with University Of California Berkley 11
Myos Enters into R&D Agreement with Cloud Pharma 12
Myos Enters Into Co-Marketing Agreement With Maximum Human Performance For MYO-T12 13
Equity Offering 14
MYOS RENS Technology Plans to Raise USD75 Million in Public Offering 14
MYOS RENS Technology to Raise up to USD6 Million in Public Offering of Shares 15
MYOS RENS Raises USD2 Million in Private Placement of Shares 16
Myos Raises USD5.2 Million in First Tranche of Private Placement of Shares and Warrants 17
Myos Raises USD1.8 Million in Private Placement of Shares 18
Myos Completes Private Placement Of Units For US$4.7 Million 20
Myos Completes Private Placement Of Shares For US$5.6 Million 21
MYOS Raises USD0.6 Million in Private Placement of Shares 22
MYOS Raises USD0.1 Million in Private Placement of Shares 23
MYOS Raises USD1 Million in Private Placement of Shares 24
Debt Offering 25
MYOS Raises USD0.6 Million in Private Placement of Notes 25
MYOS RENS Technology Inc – Key Competitors 26
MYOS RENS Technology Inc – Key Employees 27
MYOS RENS Technology Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Aug 08, 2018: MYOS RENS Technology reports 49% increase in net revenues in second quarter of 2018 29
May 09, 2018: MYOS RENS Technology Reports First Quarter Financial Results 31
Mar 27, 2018: MYOS RENS Technology Reports Fourth Quarter And Fiscal 2017 Financial Results 33
Nov 14, 2017: MYOS RENS Technology Reports Third Quarter 2017 Financial Results 35
Corporate Communications 36
Sep 20, 2017: MYOS RENS Technology Appoints Joseph Mannello as Permanent Chief Executive Officer 36
Other Significant Developments 37
Mar 28, 2018: MYOS RENS Technology CEO Joseph Mannello Provides Comments On Operational And Financial Results For Fiscal Year 2017 37
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYOS RENS Technology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Atlas Therapeutics Raises US$0.73 Million In Venture Financing 10
MYOS RENS Technology Enters into Research Agreement with University Of California Berkley 11
Myos Enters into R&D Agreement with Cloud Pharma 12
Myos Enters Into Co-Marketing Agreement With Maximum Human Performance For MYO-T12 13
MYOS RENS Technology Plans to Raise USD75 Million in Public Offering 14
MYOS RENS Technology to Raise up to USD6 Million in Public Offering of Shares 15
MYOS RENS Raises USD2 Million in Private Placement of Shares 16
Myos Raises USD5.2 Million in First Tranche of Private Placement of Shares and Warrants 17
Myos Raises USD1.8 Million in Private Placement of Shares 18
Myos Completes Private Placement Of Units For US$4.7 Million 20
Myos Completes Private Placement Of Shares For US$5.6 Million 21
MYOS Raises USD0.6 Million in Private Placement of Shares 22
MYOS Raises USD0.1 Million in Private Placement of Shares 23
MYOS Raises USD1 Million in Private Placement of Shares 24
MYOS Raises USD0.6 Million in Private Placement of Notes 25
MYOS RENS Technology Inc, Key Competitors 26
MYOS RENS Technology Inc, Key Employees 27
MYOS RENS Technology Inc, Subsidiaries 28

List of Figures
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[MYOS RENS Technology Inc (MYOS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Superior Energy Services Inc (SPN):石油・ガス:M&Aディール及び事業提携情報
    Summary Superior Energy Services Inc (Superior Energy) is a provider of equipment and production services to the energy industry. It offers drilling, completion and production-related services to independent oil and gas companies. The company also manufactures, rent and sell specialized tools and eq …
  • Warner Music Group Corp.:企業の戦略的SWOT分析
    Warner Music Group Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Asia Hotel Public Company Limited:企業の戦略・SWOT・財務情報
    Asia Hotel Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Asia Hotel Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • P.T. Telekomunikasi Selular:企業の戦略・SWOT・財務情報
    P.T. Telekomunikasi Selular - Strategy, SWOT and Corporate Finance Report Summary P.T. Telekomunikasi Selular - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tenaga Nasional Bhd (TENAGA):電力:M&Aディール及び事業提携情報
    Summary Tenaga Nasional Bhd (TNB) is an electricity utility that generates, transmits, distributes and supplies power. It develops, operates and maintains a portfolio of power generating units. The company produces electricity from crude oil, natural gas, hydro, coal and gas sources. TNB also suppli …
  • Capstone Therapeutics Corp (CAPS)-製薬・医療分野:企業M&A・提携分析
    Summary Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp is a biotechnology company that develops novel peptides and other molecules. The company develops novel peptides to support patients with under-served medical conditions. It develops AZX100 and Chrysalin drug platforms. Capstone …
  • Tyser & Co Ltd:企業の戦略的SWOT分析
    Tyser & Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • CITGO Petroleum Corp:企業の戦略的SWOT分析
    CITGO Petroleum Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Dayton Superior Corporation:企業の戦略的SWOT分析
    Dayton Superior Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Yonsei University:製薬・医療:M&Aディール及び事業提携情報
    Summary Yonsei University (Yonsei) is an educational service provider that offers training and research services. The university offers graduation programs in various areas such as applied statistics, architectural engineering, Asian studies, astronomy, atmospheric sciences, biochemistry, bio conver …
  • IFA Hotels and Resorts Company KSCC:企業の戦略・SWOT・財務情報
    IFA Hotels and Resorts Company KSCC - Strategy, SWOT and Corporate Finance Report Summary IFA Hotels and Resorts Company KSCC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Delegat’s Group Limited:企業の戦略・SWOT・財務情報
    Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Celulose Irani S.A.:企業の戦略・SWOT・財務情報
    Celulose Irani S.A. - Strategy, SWOT and Corporate Finance Report Summary Celulose Irani S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Kayne Anderson Capital Advisors LP:企業のM&A・事業提携・投資動向
    Kayne Anderson Capital Advisors LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kayne Anderson Capital Advisors LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Scottish Power Ltd:発電所・企業SWOT分析
    Scottish Power Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Unicharm Corporation (8113):企業の財務・戦略的SWOT分析
    Unicharm Corporation (8113) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • PTT Exploration and Production Public Co Ltd (PTTEP):企業の財務・戦略的SWOT分析
    PTT Exploration and Production Public Co Ltd (PTTEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Teradata Corp (TDC):企業の財務・戦略的SWOT分析
    Teradata Corp (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Factor Therapeutics Ltd (FTT):企業の財務・戦略的SWOT分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor …
  • Helix Energy Solutions Group Inc (HLX):企業の財務・戦略的SWOT分析
    Summary Helix Energy Solutions Group Inc (Helix Energy) is an oil and gas company that provides offshore energy services. The company provides well intervention, subsea engineering and contracting services. Its well intervention services comprise riserless intervention and riser based operations, st …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆